Published online Sep 27, 2024. doi: 10.4240/wjgs.v16.i9.2902
Revised: July 10, 2024
Accepted: August 5, 2024
Published online: September 27, 2024
Processing time: 97 Days and 8.7 Hours
Endoscopic transpapillary gallbladder drainage is challenging because of the complexity of the procedure and high incidence of adverse events (AEs). To overcome these problems, endoscopic gallbladder stenting (EGBS) after percu
To examine the benefits of EGBS after PTGBD to assess its efficacy and impact on AEs.
We retrospectively analyzed data from 35 patients who underwent EGBS after PTGBD at a single center between January 2016 and December 2023. The primary outcomes were technical success and AEs, and the rate of recurrent cholecystitis was evaluated. In addition, the reasons for the failure of the procedure were identified.
Among the 35 patients, the technical success rate was 77.1% and the final contrast of the cystic duct was successful in 97.1% of patients. The incidence of early AEs was relatively low (11.4%), with no instances of cystic duct perforation. The rate of recurrent cholecystitis was 3.7%, and no other biliary events were observed.
EGBS after PTGBD may be significantly beneficial, with a substantial success rate and minimal AEs in both short- and long-term follow-ups.
Core Tip: The placement of gallbladder stents is considered a technically challenging procedure and is only recommended in specialized facilities. Our findings suggest that endoscopic gallbladder stenting after percutaneous transhepatic gallbladder drainage may simplify this technique. This approach has the potential to reduce the risk of adverse events, both immediately after the procedure and in the long term, and may be beneficial for patients with a high surgical risk. This is the first study to investigate endoscopic gallbladder stenting after percutaneous transhepatic gallbladder drainage, which may have possible implications as a technique that could be a valuable addition to clinical treatment strategies.